{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2017"],"data_sharing_plan":["IPD Sharing (as of September 2022): No"],"condition":["Colorectal Cancer","Colorectal Neoplasms"],"disease":["Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2249799"],"location":["United States"],"study_start_month":["10"],"keyword":["Trifluridine"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer","description":"This research study is studying a drug in combination with radiation therapy as a possible treatment for hepatic metastases from colorectal cancer.\nThe interventions involved in this study are:\n* Trifluridine (TAS-102)\n* Radiation Therapy","dates":{"creation":"2017-10-15"},"accession":"2249799","cross_references":{"ClinicalTrials___gov":["NCT03223779"]}}